Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Long-Term Outcomes of Patients Undergoing the Ross Procedure

A. Aboud, EI. Charitos, B. Fujita, U. Stierle, JC. Reil, V. Voth, M. Liebrich, M. Andreas, T. Holubec, C. Bening, M. Albert, P. Fila, J. Ondrasek, P. Murin, R. Lange, H. Reichenspurner, U. Franke, A. Gorski, A. Moritz, G. Laufer, W. Hemmer, HH....

. 2021 ; 77 (11) : 1412-1422. [pub] 20210323

Language English Country United States

Document type Journal Article, Observational Study

Persistent link   https://www.medvik.cz/link/bmc22004522

BACKGROUND: Treatment of aortic-valve disease in young patients still poses challenges. The Ross procedure offers several potential advantages that may translate to improved long-term outcomes. OBJECTIVES: This study reports long-term outcomes after the Ross procedure. METHODS: Adult patients who were included in the Ross Registry between 1988 and 2018 were analyzed. Endpoints were overall survival, reintervention, and major adverse events at maximum follow-up. Multivariable regression analyses were performed to identify risk factors for survival and the need of Ross-related reintervention. RESULTS: There were 2,444 adult patients with a mean age of 44.1 ± 11.7 years identified. Early mortality was 1.0%. Estimated survival after 25 years was 75.8% and did not statistically differ from the general population (p = 0.189). The risk for autograft reintervention was 0.69% per patient-year and 0.62% per patient-year for right-ventricular outflow tract (RVOT) reintervention. Larger aortic annulus diameter (hazard ratio [HR]: 1.12/mm; 95% confidence interval [CI]: 1.05 to 1.19/mm; p < 0.001) and pre-operative presence of pure aortic insufficiency (HR: 1.74; 95% CI: 1.13 to 2.68; p = 0.01) were independent predictors for autograft reintervention, whereas the use of a biological valve (HR: 8.09; 95% CI: 5.01 to 13.08; p < 0.001) and patient age (HR: 0.97 per year; 95% CI: 0.96 to 0.99; p = 0.001) were independent predictors for RVOT reintervention. Major bleeding, valve thrombosis, permanent stroke, and endocarditis occurred with an incidence of 0.15% per patient-year, 0.07% per patient-year, 0.13%, and 0.36% per patient-year, respectively. CONCLUSIONS: The Ross procedure provides excellent survival over a follow-up period of up to 25 years. The rates of reintervention, anticoagulation-related morbidity, and endocarditis were very low. This procedure should therefore be considered as a very suitable treatment option in young patients suffering from aortic-valve disease. (Long-Term Follow-up After the Autograft Aortic Valve Procedure [Ross Operation]; NCT00708409).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004522
003      
CZ-PrNML
005      
20230302135518.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jacc.2021.01.034 $2 doi
035    __
$a (PubMed)33736823
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Aboud, Anas $u Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck Campus, Lübeck, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Lübeck, Lübeck, Germany. Electronic address: Anas.Aboud@uksh.de
245    10
$a Long-Term Outcomes of Patients Undergoing the Ross Procedure / $c A. Aboud, EI. Charitos, B. Fujita, U. Stierle, JC. Reil, V. Voth, M. Liebrich, M. Andreas, T. Holubec, C. Bening, M. Albert, P. Fila, J. Ondrasek, P. Murin, R. Lange, H. Reichenspurner, U. Franke, A. Gorski, A. Moritz, G. Laufer, W. Hemmer, HH. Sievers, S. Ensminger
520    9_
$a BACKGROUND: Treatment of aortic-valve disease in young patients still poses challenges. The Ross procedure offers several potential advantages that may translate to improved long-term outcomes. OBJECTIVES: This study reports long-term outcomes after the Ross procedure. METHODS: Adult patients who were included in the Ross Registry between 1988 and 2018 were analyzed. Endpoints were overall survival, reintervention, and major adverse events at maximum follow-up. Multivariable regression analyses were performed to identify risk factors for survival and the need of Ross-related reintervention. RESULTS: There were 2,444 adult patients with a mean age of 44.1 ± 11.7 years identified. Early mortality was 1.0%. Estimated survival after 25 years was 75.8% and did not statistically differ from the general population (p = 0.189). The risk for autograft reintervention was 0.69% per patient-year and 0.62% per patient-year for right-ventricular outflow tract (RVOT) reintervention. Larger aortic annulus diameter (hazard ratio [HR]: 1.12/mm; 95% confidence interval [CI]: 1.05 to 1.19/mm; p < 0.001) and pre-operative presence of pure aortic insufficiency (HR: 1.74; 95% CI: 1.13 to 2.68; p = 0.01) were independent predictors for autograft reintervention, whereas the use of a biological valve (HR: 8.09; 95% CI: 5.01 to 13.08; p < 0.001) and patient age (HR: 0.97 per year; 95% CI: 0.96 to 0.99; p = 0.001) were independent predictors for RVOT reintervention. Major bleeding, valve thrombosis, permanent stroke, and endocarditis occurred with an incidence of 0.15% per patient-year, 0.07% per patient-year, 0.13%, and 0.36% per patient-year, respectively. CONCLUSIONS: The Ross procedure provides excellent survival over a follow-up period of up to 25 years. The rates of reintervention, anticoagulation-related morbidity, and endocarditis were very low. This procedure should therefore be considered as a very suitable treatment option in young patients suffering from aortic-valve disease. (Long-Term Follow-up After the Autograft Aortic Valve Procedure [Ross Operation]; NCT00708409).
650    _2
$a dospělí $7 D000328
650    12
$a aortální chlopeň $x patologie $x chirurgie $7 D001021
650    12
$a onemocnění aortální chlopně $x diagnóza $x epidemiologie $x chirurgie $7 D000082862
650    _2
$a echokardiografie $x metody $7 D004452
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční chlopně umělé $x škodlivé účinky $x statistika a číselné údaje $7 D006350
650    12
$a chirurgická náhrada chlopně $x škodlivé účinky $x přístrojové vybavení $x metody $7 D019918
650    _2
$a lidé $7 D006801
650    12
$a dlouhodobé vedlejší účinky $x diagnóza $x epidemiologie $x etiologie $7 D000069451
650    _2
$a mužské pohlaví $7 D008297
650    12
$a pooperační komplikace $x diagnóza $x epidemiologie $x etiologie $x chirurgie $7 D011183
650    _2
$a prognóza $7 D011379
650    _2
$a registrace $x statistika a číselné údaje $7 D012042
650    12
$a reoperace $x klasifikace $x metody $x statistika a číselné údaje $7 D012086
650    _2
$a hodnocení rizik $x metody $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a analýza přežití $7 D016019
650    12
$a autologní transplantace $x škodlivé účinky $x metody $7 D014182
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Německo $x epidemiologie $7 D005858
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Charitos, Efstratios I $u Department of Cardiac Surgery, University of Bonn, Bonn, Germany
700    1_
$a Fujita, Buntaro $u Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck Campus, Lübeck, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Lübeck, Lübeck, Germany
700    1_
$a Stierle, Ulrich $u Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck Campus, Lübeck, Germany
700    1_
$a Reil, Jan-Christian $u Department of Cardiology, University Hospital Schleswig-Holstein, Lübeck Campus, Lübeck, Germany
700    1_
$a Voth, Vladimir $u Sana Cardiac Surgery Stuttgart, Stuttgart, Germany
700    1_
$a Liebrich, Markus $u Sana Cardiac Surgery Stuttgart, Stuttgart, Germany
700    1_
$a Andreas, Martin $u Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria
700    1_
$a Holubec, Tomas $u Department of Thoracic and Cardiovascular Surgery, University Hospital Frankfurt, Frankfurt, Germany
700    1_
$a Bening, Constanze $u Department of Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Albert, Marc $u Department of Cardiac and Vascular Surgery, Robert-Bosch-Hospital, Stuttgart, Germany
700    1_
$a Fila, Petr $u Centre of Cardiovascular Surgery and Transplantation, Brno, Czech Republic
700    1_
$a Ondrasek, Jiri $u Centre of Cardiovascular Surgery and Transplantation, Brno, Czech Republic
700    1_
$a Murin, Peter $u Department of Congenital Heart Disease and Paediatric Cardiology, German Heart Center, Berlin, Germany
700    1_
$a Lange, Rüdiger, $u Department of Cardiovascular Surgery, German Heart Center, Munich, Germany $d 1953- $7 xx0282824
700    1_
$a Reichenspurner, Hermann $u Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
700    1_
$a Franke, Ulrich $u Department of Cardiac and Vascular Surgery, Robert-Bosch-Hospital, Stuttgart, Germany
700    1_
$a Gorski, Armin $u Department of Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Moritz, Anton $u Department of Thoracic and Cardiovascular Surgery, University Hospital Frankfurt, Frankfurt, Germany
700    1_
$a Laufer, Günther $u Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria
700    1_
$a Hemmer, Wolfgang $u Sana Cardiac Surgery Stuttgart, Stuttgart, Germany
700    1_
$a Sievers, Hans-Hinrich $u Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck Campus, Lübeck, Germany
700    1_
$a Ensminger, Stephan $u Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck Campus, Lübeck, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Lübeck, Lübeck, Germany
773    0_
$w MED00002964 $t Journal of the American College of Cardiology $x 1558-3597 $g Roč. 77, č. 11 (2021), s. 1412-1422
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33736823 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20230302135512 $b ABA008
999    __
$a ok $b bmc $g 1751855 $s 1155671
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 77 $c 11 $d 1412-1422 $e 20210323 $i 1558-3597 $m Journal of the American College of Cardiology $n J. Am. Coll. Cardiol. $x MED00002964
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options